The first global, truly digital, full-service CRO
The first global, truly digital, full-service CRO
Exom is globally acting full-service CRO committed to the modernization of clinical trials through implementation of innovative digital solutions. Since 2021, Exom us part if Clinscience, the CRO of Neuca Group. In 2023, Oncobay joined the company group, expanding our Geographical footprint to North America and the APAC Region.
By combining our expertise in managing clinical trials with our proprietary, multi-modular and cloud-based platform Genius SUITE™, Exom improves efficiencies and escalates process speeds, while ensuring high-quality data and cost reduction, from early phase to late stage & outcome studies. We are providing our services and solutions for Phase I-IV studies, NISs and Investigator Initiated Trials on drugs, nutraceuticals, and medical devices.
Our Mission is to implement the next generation clinical trial 5.0 processes, through the combination of human expertise with the efficiency of digital technologies and advanced analytics to provide our customers with value added services and exceptional study experience.
Our international network qualified Partners (Exom Alliance), trained to Exom’s technologies and processes, provides an established organization, active across the whole of Europe, North America and other important markets. Our mission is to innovate clinical research with passion, integrity, transparency, caring and innovation.
Consulting
Study- & Protocol Design
Feasibility & Site Selection
Regulatory Services
Medical Writing
Study Management
Data-Driven and Risk-Based
Monitoring and Management
Central Event Adjudication
Data Management
Statistical Analysis
Report Writing
Medical Monitoring & PV
Lab Support Services
Quality Assurance
Auditing
Trial Supply Management
Peri & Post Approval & IITs
Our Vision is to…
Transform clinical trials conduction by connecting scientific expertise with advanced digital technologies and newly re-engineered operational processes.
Assure the achievement of high-quality standards and prevent any risk that could potentially harm study results.
Operate through data-driven management and risk-based monitoring (DDM & RBM) approach.
Reduce the overall costs while increasing quality and performance.
Therapeutic Expertise
Exom’s Clinical research professionals share the passion for quality and performance through the digital innovation of working processes. They have a solid expertise and experience (average 6-7 years) in clinical trials conduct.
- Oncology & Hematology
- Cardiovascular & Metabolic Diseases
- Central Nervous System (CNS) Disorders
- Rare Diseases
- Respiratory
- Infectious Diseases
- Urology
- Gastroenterology
- Critical Care
- Immunology
Therapeutic Expertise
Exom’s Clinical research professionals share the passion for quality and performance through the digital innovation of working processes. They have a solid expertise and experience (average 6-7 years) in clinical trials conduct.
[sg_popup id=4176]
- Oncology & Hematology
- Cardiovascular & Metabolic Diseases
- Central Nervous System (CNS) Disorders
- Rare Diseases
- Respiratory
- Infectious Diseases
- Urology
- Gastroenterology
- Critical Care
- Immunology
Storm Reply Helps Exom Group Automate Remote Patient Consent Using AWS Chatbot Technology
Executive Summary Exom, a digital-first contract research organization (CRO), worked with AWS Partner Storm Reply to build a reliable and compliant chatbot using artificial intelligence (AI) on Amazon Web Services (AWS). The solution guides remote participants using...
Geremy Project: Exom is part of a project to find a genetic cure for cardiomyopathy
Europe's research and innovation funding programme Horizon2020 has granted research teams 8M euro funding for developing new effective therapies for rare diseases. Exom Group is proud to be a member of this consortium, called GEREMY. This project aims to find a cure...